Related Experiment Video
Updated: May 18, 2026
08:33
Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
Sumoylation in neurodegenerative diseases
Petranka Krumova1, Jochen H Weishaupt
1Neuroscience, Novartis Institutes for Biomedical Research, Novartis Pharma AG, 4002, Basel, Switzerland. petranka.krumova@novartis.com
Cellular and Molecular Life Sciences : CMLS
|September 26, 2012
Summary
Sumoylation, a protein modification, regulates diverse cellular processes and is increasingly recognized for its role in neurodegenerative diseases. This review explores sumoylation
Area of Science:
- Molecular Biology
- Biochemistry
- Neuroscience
Background:
- Sumoylation is a post-translational modification involving small ubiquitin-like modifier (SUMO) proteins.
- SUMOylation, similar to ubiquitination, attaches SUMO proteins to lysine residues on target proteins.
- SUMOylation impacts numerous cellular functions, including transcription, protein localization, and apoptosis.
Purpose of the Study:
- To review the involvement of sumoylation in neurodegenerative diseases.
- To discuss the molecular mechanisms by which sumoylation influences neurodegeneration.
- To highlight sumoylation as a regulator of toxic protein properties in neurodegeneration.
Main Methods:
- Literature review of studies on sumoylation and neurodegeneration.
- Analysis of molecular principles underlying sumoylation's role in disease.
- Synthesis of current knowledge on SUMO protein interactions and functions.
Main Results:
- Sumoylation plays a multifaceted role in regulating cellular processes.
- Emerging evidence links sumoylation to the pathogenesis of neurodegenerative diseases.
- SUMOylation can modulate protein interactions and create/block interaction domains.
Conclusions:
- Sumoylation is a critical post-translational modification with significant implications for neurodegeneration.
- Understanding sumoylation's role offers potential therapeutic strategies for neurodegenerative disorders.
- Further research is needed to fully elucidate the complex mechanisms of sumoylation in disease.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:02Phosphorylation
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...